Details for New Drug Application (NDA): 072164
✉ Email this page to a colleague
NDA 072164 describes MAPROTILINE HYDROCHLORIDE, which is a drug marketed by Am Therap, Heritage Pharma, Rising, and Watson Labs, and is included in ten NDAs. Additional details are available on the MAPROTILINE HYDROCHLORIDE profile page.
The generic ingredient in MAPROTILINE HYDROCHLORIDE is maprotiline hydrochloride. There are three drug master file entries for this compound. Additional details are available on the maprotiline hydrochloride profile page.
The generic ingredient in MAPROTILINE HYDROCHLORIDE is maprotiline hydrochloride. There are three drug master file entries for this compound. Additional details are available on the maprotiline hydrochloride profile page.
Summary for 072164
| Tradename: | MAPROTILINE HYDROCHLORIDE |
| Applicant: | Watson Labs |
| Ingredient: | maprotiline hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072164
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 75MG | ||||
| Approval Date: | Jun 1, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
